Novartis Ag (NVS) Intangibles (2009 - 2026)

Novartis Ag (NVS) posted Intangibles of $11.3 billion for Q1 2026, down 61.58% sequentially from $29.4 billion in Q4 2025.

Novartis Ag (NVS) Intangibles (2009 - 2026) Analysis & Trends

Novartis Ag (NVS) has 12 years of Intangibles data on file, last reported at $11.3 billion in Q1 2026.

  • Quarterly Intangibles changed N/A year-over-year to $11.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.3 billion (changed N/A YoY) and the FY2025 annual result came in at $29.4 billion, up 9.27% from the prior year.
  • Intangibles eased to $11.3 billion in Q1 2026 per NVS's latest filing, from $29.4 billion in the prior quarter.
  • The five-year high for Intangibles was $58.3 billion in Q4 2023, with the low at -$2.6 billion in Q4 2022.
  • Average Intangibles over 5 years is $21.0 billion, with a median of $27.3 billion recorded in 2024.
  • Year-over-year, Intangibles soared 2667.09% in 2023 and plunged 53.85% in 2024.
  • Novartis Ag's Intangibles stood at -$2.6 billion in 2022, then soared by 2314.93% to $58.3 billion in 2023, then sank by 53.85% to $26.9 billion in 2024, then increased by 9.27% to $29.4 billion in 2025, then slumped by 61.58% to $11.3 billion in 2026.
  • Business Quant data shows NVS's Intangibles at $11.3 billion in Q1 2026, $29.4 billion in Q4 2025, and $29.2 billion in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 7.37 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 49.06 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 50.87 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 36.91 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 25.75 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 21.38 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 16.38 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 52.56 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - 11.30 Bn
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn 9.05 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 11.30 Bn
Dec 31, 2025 29.41 Bn
Jun 30, 2025 29.24 Bn
Dec 31, 2024 26.92 Bn
Jun 30, 2024 27.78 Bn
Dec 31, 2023 58.32 Bn
Jun 30, 2023 28.00 Bn
Dec 31, 2022 -2.63 Bn
Jun 30, 2022 1.01 Bn
Mar 31, 2022 901.00 Mn
Dec 31, 2021 -2.41 Bn
Sep 30, 2021 307.00 Mn
Jun 30, 2021 145.00 Mn
Mar 31, 2021 123.00 Mn
Dec 31, 2020 -26.57 Bn
Sep 30, 2020 218.00 Mn
Jun 30, 2020 7.57 Bn
Dec 31, 2019 7.43 Bn
Jun 30, 2019 411.00 Mn
Mar 31, 2019 505.00 Mn